Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is b
Digital transformation; it would be easy to assume that it is widespread across the life science industry, and yet while it is true to say that every company in the sector will have made inroads in
The National Institute for Health and Care Excellence (NICE) process for single technology appraisals (STA) has been established for many years with clear cost effectiveness thresholds.
Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking for a wider view when looking for insights to inform their branding?
